Clarifying the legal landscape of psilocybin regulation: A medico-legal perspective
No abstract is available for this record.
Bibliographic context
- Journal
- Drug Science Policy and Law
- Date
- 2025-03-31
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behaviorNeuroscience Applied · 2024-12-31Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adultsNeuroscience Applied · 2025-12-31Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental modelsFrontiers in Systems Neuroscience · 2025-08-04Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin ConsumptionBehavioral Sciences · 2026-04-29Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?Medical Sciences · 2025-11-19The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?Exploration of neuroscience · 2025-08-06Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamineNeuroscience · 2025-07-31